{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:10:47Z","timestamp":1780337447619,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["NRF-2016R1D1A1B03934099"],"award-info":[{"award-number":["NRF-2016R1D1A1B03934099"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.intimp.2020.106553","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T12:29:47Z","timestamp":1592396987000},"page":"106553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Therapeutic anti-psoriatic effects of myeloid-derived suppressor cells in combination with systemic tacrolimus (FK-506) in an imiquimod-induced mouse model of psoriasis"],"prefix":"10.1016","volume":"86","author":[{"given":"Mi-Young","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Kug","family":"Choo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Ho","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won-Gu","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo-Hee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2020.106553_b0005","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","volume":"361","author":"Nestle","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2020.106553_b0010","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"Boehncke","year":"2015","journal-title":"Psoriasis. Lancet"},{"key":"10.1016\/j.intimp.2020.106553_b0015","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/cmi.2012.15","article-title":"New insights of T cells in the pathogenesis of psoriasis","volume":"9","author":"Cai","year":"2012","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2020.106553_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2004.02310.x","article-title":"Immunopathogenic mechanisms in psoriasis","volume":"135","author":"Gudjonsson","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2020.106553_b0025","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2020.106553_b0030","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-4632.2011.05154.x","article-title":"The roles of cells and cytokines in the pathogenesis of psoriasis","volume":"51","author":"Coimbra","year":"2012","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.intimp.2020.106553_b0035","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.autrev.2014.11.012","article-title":"T cell responses in psoriasis and psoriatic arthritis","volume":"14","author":"Diani","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2020.106553_b0040","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1053\/j.gastro.2008.06.032","article-title":"Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway","volume":"135","author":"Haile","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2020.106553_b0045","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.4049\/jimmunol.1101816","article-title":"Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune disease","volume":"188","author":"Ioannou","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2020.106553_b0050","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/eji.201444799","article-title":"Functional characterization of myeloid-derived suppressor cell subpopulations during the development of experimental arthritis","volume":"45","author":"Wang","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2020.106553_b0055","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1002\/art.39767","article-title":"Myeloid-derived suppressor cells induce the expansion of regulatory B cells and ameliorate autoimmunity in the sanroque mouse odel of systemic lupus erythematosus","volume":"68","author":"Park","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.intimp.2020.106553_b0060","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12742","article-title":"Anti-psoriatic effect of myeloid-derived suppressor cells on imiquimod-induced skin inflammation in mice","volume":"89","author":"Kim","year":"2019","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.intimp.2020.106553_b0065","article-title":"Topical and oral therapies for childhood atopic dermatitis and plaque psoriasis","author":"Frantz","year":"2019","journal-title":"Children (Basel)"},{"key":"10.1016\/j.intimp.2020.106553_b0070","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jdermsci.2016.12.015","article-title":"Differences in therapeutic effects of topically applied corticosteroid and tacrolimus on atopic dermatitis-like symptoms in NC\/Nga mice","volume":"86","author":"Noguchi","year":"2017","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.intimp.2020.106553_b0075","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jconrel.2016.09.007","article-title":"Improved topical delivery of tacrolimus: a novel composite hydrogel formulation for the treatment of psoriasis","volume":"242","author":"Gabriel","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.intimp.2020.106553_b0080","first-page":"94","article-title":"Combination therapy in the treatment of psoriasis","volume":"9","author":"Domm","year":"2011","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"10.1016\/j.intimp.2020.106553_b0085","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/jamadermatol.2014.1111","article-title":"Combined use of systemic agents for psoriasis: a systematic review","volume":"150","author":"Busard","year":"2014","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.intimp.2020.106553_b0090","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-3083.2011.02659.x","article-title":"Therapeutic effects of combination using glucosamine plus tacrolimus (FK-506) on the development of atopic dermatitis-like skin lesions in NC\/Nga mice","volume":"75","author":"Kim","year":"2012","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.intimp.2020.106553_b0095","doi-asserted-by":"crossref","first-page":"16322","DOI":"10.1038\/s41598-019-52892-1","article-title":"Calcipotriol and betamethasone dipropionate synergistically enhances the balance between regulatory and proinflammatory T cells in a murine psoriasis model","volume":"9","author":"Satake","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2020.106553_b0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejphar.2015.03.010","article-title":"Therapeutic and immunomodulatory effects of glucosamine in combination with low-dose cyclosporine a in a murine model of imiquimod-induced psoriasis","volume":"756","author":"Kim","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2020.106553_b0105","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jaad.2009.03.027","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents","volume":"61","author":"Menter","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.intimp.2020.106553_b0110","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.intimp.2013.01.005","article-title":"Mechanism underlying the effect of combined therapy using glucosamine and low-dose cyclosporine A on the development of atopic dermatitis-like skin lesions in NC\/Nga mice","volume":"15","author":"Kim","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2020.106553_b0115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.imlet.2016.08.012","article-title":"Protective effects of agonistic anti-4-1BB antibody on the development of imiquimod-induced psoriasis-like dermatitis in mice","volume":"178","author":"Yoo","year":"2016","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.intimp.2020.106553_b0120","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2020.106553_b0125","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/1346-8138.12367","article-title":"Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell ctivation by imiquimod","volume":"41","author":"Ueyama","year":"2014","journal-title":"J. Dermatol."},{"key":"10.1016\/j.intimp.2020.106553_b0130","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1038\/jid.2014.98","article-title":"IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A producing \u03b3\u03b4 T cells","volume":"134","author":"Yoshiki","year":"2014","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.intimp.2020.106553_b0135","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12016-016-8535-x","article-title":"The inflammatory response in psoriasis: a comprehensive review","volume":"50","author":"Deng","year":"2016","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.intimp.2020.106553_b0140","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1189\/jlb.4A0314-139R","article-title":"Myeloid-derived suppressor cells regulate T cell and B cell responses during autoimmune disease","volume":"97","author":"Crook","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.intimp.2020.106553_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2058738418778724","article-title":"Combinatory treatment using tacrolimus and a STAT3 inhibitor regulate Treg cells and plasma cells","volume":"32","author":"Park","year":"2018","journal-title":"Int.. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.intimp.2020.106553_b0150","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/exd.12649","article-title":"Osteopontin deficiency affects imiquimod-induced psoriasis-like murine skin inflammation and lymphocyte distribution in skin, draining lymph nodes and spleen","volume":"24","author":"Frenzel","year":"2015","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.intimp.2020.106553_b0155","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.coi.2003.09.012","article-title":"Role of regulatory T cells in allergy and asthma","volume":"15","author":"Akbari","year":"2003","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.intimp.2020.106553_b0160","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nri2889","article-title":"Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases","volume":"10","author":"Buckner","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2020.106553_b0165","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.4049\/jimmunol.1000557","article-title":"Inflammatory effects of ex vivo human Th17 cells are suppressed by regulatory T cells","volume":"185","author":"Crome","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2020.106553_b0170","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/TP.0b013e3182590d8f","article-title":"In vitro effects of cyclosporine A and tacrolimus on regulatory T-cell proliferation and function","volume":"94","author":"Miroux","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.intimp.2020.106553_b0175","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1038\/s41598-018-21856-2","article-title":"Interleukin-10 produced by myeloid-derived suppressor cells is critical for the induction of Tregs and attenuation of rheumatoid inflammation in mice","volume":"8","author":"Park","year":"2018","journal-title":"Sci. Rep."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920309954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920309954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:56:11Z","timestamp":1769028971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576920309954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":35,"alternative-id":["S1567576920309954"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106553","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic anti-psoriatic effects of myeloid-derived suppressor cells in combination with systemic tacrolimus (FK-506) in an imiquimod-induced mouse model of psoriasis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106553","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106553"}}